Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L W Lawrence

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Organic & Biomolecular Chemistry|November 2, 2007
Dual aromatase-sulfatase inhibitors based on the anastrozole template: synthesis, in vitro SAR, molecular modelling and in vivo activityToby Jackson, L W Lawrence Woo, Melanie N Trusselle, et al.
Annals of the New York Academy of Sciences|March 3, 2009
The development of steroid sulfatase inhibitors for hormone-dependent cancer therapyJoanna M Day, Atul Purohit, Helena J Tutill, et al.
The Journal of Steroid Biochemistry and Molecular Biology|April 25, 2003
Novel D-ring modified steroid derivatives as potent, non-estrogenic, steroid sulfatase inhibitors with in vivo activityDelphine S Fischer, Surinder K Chander, L W Lawrence Woo, et al.
Journal of Medicinal Chemistry|July 11, 2003
First dual aromatase-steroid sulfatase inhibitorsL W Lawrence Woo, Oliver B Sutcliffe, Christian Bubert, et al.
Chemmedchem|October 13, 2011
Structure-activity relationship for the first-in-class clinical steroid sulfatase inhibitor Irosustat (STX64, BN83495)L W Lawrence Woo, Dharshini Ganeshapillai, Mark P Thomas, et al.
Biochemical and Biophysical Research Communications|March 30, 2004
2-difluoromethyloestrone 3-O-sulphamate, a highly potent steroid sulphatase inhibitorJulie E Reed, L W Lawrence Woo, James J Robinson, et al.
The Biochemical Journal|September 30, 2004
Crystal structure of human carbonic anhydrase II at 1.95 A resolution in complex with 667-coumate, a novel anti-cancer agentMatthew D Lloyd, Richard L Pederick, Ramanathan Natesh, et al.
Chemmedchem|September 26, 2008
Synthesis of aromatase inhibitors and dual aromatase steroid sulfatase inhibitors by linking an arylsulfamate motif to 4-(4H-1,2,4-triazol-4-ylamino)benzonitrile: SAR, crystal structures, in vitro and in vivo activitiesChristian Bubert, L W Lawrence Woo, Oliver B Sutcliffe, et al.
Chembiochem : a European Journal of Chemical Biology|February 22, 2008
Direct evidence for ArO-S bond cleavage upon inactivation of Pseudomonas aeruginosa arylsulfatase by aryl sulfamatesPavla Bojarová, Emma Denehy, Ian Walker, et al.
Journal of Medicinal Chemistry|June 22, 2007
Dual aromatase-steroid sulfatase inhibitorsL W Lawrence Woo, Christian Bubert, Oliver B Sutcliffe, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Organic & Biomolecular Chemistry|November 2, 2007
Dual aromatase-sulfatase inhibitors based on the anastrozole template: synthesis, in vitro SAR, molecular modelling and in vivo activityToby Jackson, L W Lawrence Woo, Melanie N Trusselle, et al.
Annals of the New York Academy of Sciences|March 3, 2009
The development of steroid sulfatase inhibitors for hormone-dependent cancer therapyJoanna M Day, Atul Purohit, Helena J Tutill, et al.
The Journal of Steroid Biochemistry and Molecular Biology|April 25, 2003
Novel D-ring modified steroid derivatives as potent, non-estrogenic, steroid sulfatase inhibitors with in vivo activityDelphine S Fischer, Surinder K Chander, L W Lawrence Woo, et al.
Journal of Medicinal Chemistry|July 11, 2003
First dual aromatase-steroid sulfatase inhibitorsL W Lawrence Woo, Oliver B Sutcliffe, Christian Bubert, et al.
Chemmedchem|October 13, 2011
Structure-activity relationship for the first-in-class clinical steroid sulfatase inhibitor Irosustat (STX64, BN83495)L W Lawrence Woo, Dharshini Ganeshapillai, Mark P Thomas, et al.
Biochemical and Biophysical Research Communications|March 30, 2004
2-difluoromethyloestrone 3-O-sulphamate, a highly potent steroid sulphatase inhibitorJulie E Reed, L W Lawrence Woo, James J Robinson, et al.
The Biochemical Journal|September 30, 2004
Crystal structure of human carbonic anhydrase II at 1.95 A resolution in complex with 667-coumate, a novel anti-cancer agentMatthew D Lloyd, Richard L Pederick, Ramanathan Natesh, et al.
Chemmedchem|September 26, 2008
Synthesis of aromatase inhibitors and dual aromatase steroid sulfatase inhibitors by linking an arylsulfamate motif to 4-(4H-1,2,4-triazol-4-ylamino)benzonitrile: SAR, crystal structures, in vitro and in vivo activitiesChristian Bubert, L W Lawrence Woo, Oliver B Sutcliffe, et al.
Chembiochem : a European Journal of Chemical Biology|February 22, 2008
Direct evidence for ArO-S bond cleavage upon inactivation of Pseudomonas aeruginosa arylsulfatase by aryl sulfamatesPavla Bojarová, Emma Denehy, Ian Walker, et al.
Journal of Medicinal Chemistry|June 22, 2007
Dual aromatase-steroid sulfatase inhibitorsL W Lawrence Woo, Christian Bubert, Oliver B Sutcliffe, et al.
Pageof 4